NASDAQ:IRIX - IRIDEX Stock Price, Forecast & News

IRIDEX trades on the NASDAQ under the ticker symbol "IRIX."

IRIDEX Co. (NASDAQ:IRIX) issued its quarterly earnings data on Thursday, November, 7th. The medical equipment provider reported ($0.13) EPS for the quarter, beating the consensus estimate of ($0.18) by $0.05. The medical equipment provider earned $10.66 million during the quarter, compared to analyst estimates of $10.08 million. IRIDEX had a negative return on equity of 37.78% and a negative net margin of 23.42%. View IRIDEX's Earnings History.

IRIDEX is scheduled to release their next quarterly earnings announcement on Tuesday, March 3rd 2020. View Earnings Estimates for IRIDEX.

IRIDEX issued an update on its fourth quarter 2019 After-Hours earnings guidance on Monday, January, 13th. The company provided EPS guidance of for the period. The company issued revenue guidance of $11.6-11.8 million, compared to the consensus revenue estimate of $10.88 million.

News coverage about IRIX stock has trended positive this week, according to InfoTrie Sentiment. The research firm identifies negative and positive media coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. IRIDEX earned a coverage optimism score of 3.0 on InfoTrie's scale. They also gave press coverage about the medical equipment provider a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the next few days. View News Stories for IRIDEX.

IRIDEX saw a decrease in short interest in the month of January. As of January 31st, there was short interest totalling 78,800 shares, a decrease of 12.0% from the January 15th total of 89,500 shares. Based on an average daily volume of 70,900 shares, the days-to-cover ratio is currently 1.1 days. Approximately 0.7% of the company's shares are sold short. View IRIDEX's Current Options Chain.

Some companies that are related to IRIDEX include Fonar (FONR), Soleno Therapeutics (SLNO), Edap Tms (EDAP), BioSig Technologies (BSGM), Second Sight Medical Products (EYES), Fc Global Realty (FCRE), Helius Medical Technologies (HSDT), electroCore (ECOR), Precision Optics (PEYE), ENDRA Life Sciences (NDRA), Digirad (DRAD), Vaso (VASO), Non-Invasive Monitoring Systems (NIMU), Reshape Lifesciences (RSLS) and Viveve Medical (VIVE).

Based on aggregate information from My MarketBeat watchlists, some companies that other IRIDEX investors own include SCYNEXIS (SCYX), NovaBay Pharmaceuticals (NBY), Agile Therapeutics (AGRX), CTI BioPharma (CTIC), Gilead Sciences (GILD), Trevena (TRVN), AbbVie (ABBV), Allena Pharmaceuticals (ALNA), Capstone Turbine (CPST) and Fate Therapeutics (FATE).

IRIDEX's stock is owned by many different of retail and institutional investors. Top institutional investors include Renaissance Technologies LLC (3.43%), Isthmus Partners LLC (1.54%), Perkins Capital Management Inc. (0.39%), Gabelli Funds LLC (0.11%) and Blair William & Co. IL (0.09%). Company insiders that own IRIDEX stock include Associates & Paragon A Paragon, Robert Earle Grove, Romeo R Dizon, Scott Shuda and William M Moore. View Institutional Ownership Trends for IRIDEX.

IRIX stock was sold by a variety of institutional investors in the last quarter, including Blair William & Co. IL and Gabelli Funds LLC. View Insider Buying and Selling for IRIDEX.

IRIX stock was bought by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, Isthmus Partners LLC and Perkins Capital Management Inc.. Company insiders that have bought IRIDEX stock in the last two years include Associates & Paragon A Paragon, Robert Earle Grove, Scott Shuda and William M Moore. View Insider Buying and Selling for IRIDEX.

Shares of IRIX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of IRIX stock can currently be purchased for approximately $3.04.

IRIDEX has a market capitalization of $41.87 million and generates $42.60 million in revenue each year. The medical equipment provider earns $-12,810,000.00 in net income (profit) each year or ($1.05) on an earnings per share basis. View Additional Information About IRIDEX.

The official website for IRIDEX is http://www.iridex.com/.

IRIDEX's mailing address is 1212 Terra Bella Avenue, Mountain View CA, 94043. The medical equipment provider can be reached via phone at 650-940-4700 or via email at [email protected]